Home » Topics » BioWorld Science

BioWorld Science
RSS

Biocytogen and CtM Biotech to develop novel immunotherapy candidates

April 19, 2022

Microbe-sensing mechanism via neuronal Nod2 regulates appetite and metabolism

April 19, 2022

Cellectis details activity of allogeneic CAR-T cells targeting CD20 and CD22: UCART20x22

April 19, 2022

Shanghai Meiyue Biotech Development patents pantetheinase inhibitors

April 19, 2022

New MAP4K1 inhibitors identified at Shenzhen Ionova Life Science

April 19, 2022

Medshine Discovery presents new PTPN11 inhibitors

April 19, 2022

New Bruton tyrosine kinase inhibitors synthesized at GenFleet Therapeutics

April 19, 2022

Shanghai Ringene Biopharma discovers S-adenosylmethionine synthase isoform type-2 inhibitors

April 19, 2022

INBRX-130: a novel bispecific antibody targeting 5T4 and CD3

April 19, 2022

Anti-CLDN18.2/CD47 antibody PT-886 shows antitumoral activity in model of pancreatic cancer

April 19, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...